Intrinsiqs

Is Bristol-Myers Squibb Company overvalued?

Bristol-Myers Squibb Company (BMY) looks fairly valued — trading about 10% below its fair value.

Fairly valued
Current price $63.70 Fair value $70.12
Price
$63.70
Fair value
$70.12
Current P/E
18.5
Normal P/E
20.3
Market cap
$130.12B
Dividend yield
3.9%
Return on equity
46.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.